Jiyu Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Jiyu Biotechnology - overview
Established
2019
Location
Nanjing, Jiangsu, China
Primary Industry
Biotechnology
About
Established in 2019 and based in Nanjing, China, Jiyu Biotechnology operates as a medical technology service provider dedicated to providing pet healthcare products and services. In July 2024, it closed strategic investment from new investor Taipu Life Sciences Investment. The company mainly provides pet healthcare products and services. It also provides pet pharmaceutical raw materials and preparations.
The company generates revenue by providing pet healthcare products, pet pharmaceutical raw materials and preparations, and pet healthcare services.
Current Investors
Taipu Life Sciences Investment
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceuticals
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Jiyu Biotechnology - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Unspecified Round | Completed | Jiyu Biotechnology | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.